Allena Pharmaceuticals, Inc.
CIK 1624658 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Allena Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jun 12, 2023 | SEC STAFF ACTION | 9999999997-23-003169 |
| Feb 14, 2023 | SC 13G/A | 0001193125-23-039093 |
| Nov 14, 2022 | NT 10-Q | 0001193125-22-284527 |
| Sep 14, 2022 | 25-NSE | 0001354457-22-000520 |
| Sep 7, 2022 | 8-K | 0000950170-22-018183 |
| Sep 2, 2022 | 8-K | 0001193125-22-237990 |
| Aug 24, 2022 | 8-K | 0000950170-22-017733 |
| Aug 15, 2022 | 10-Q | 0000950170-22-017398 |
| Aug 11, 2022 | 8-K | 0001193125-22-218012 |
| Aug 4, 2022 | 8-K | 0001193125-22-212577 |
| Jul 13, 2022 | DEFA14A | 0001193125-22-192882 |
| Jul 12, 2022 | DEFA14A | 0001193125-22-192007 |
| Jul 12, 2022 | 8-K | 0001193125-22-192011 |
| Jul 11, 2022 | 424B5 | 0001193125-22-190953 |
| Jul 11, 2022 | 8-K | 0001193125-22-190954 |
| Jul 8, 2022 | 8-K | 0001193125-22-190576 |
| Jul 5, 2022 | DEFA14A | 0001193125-22-187538 |
| Jul 5, 2022 | 8-K | 0001193125-22-187535 |
| Jun 28, 2022 | 8-K | 0000950170-22-012267 |
| Jun 23, 2022 | S-1 | 0001193125-22-180237 |
| Jun 22, 2022 | 8-K | 0000950170-22-011963 |
| May 24, 2022 | DEF 14A | 0001193125-22-158031 |
| May 24, 2022 | DEFA14A | 0001193125-22-158034 |
| May 17, 2022 | D | 0001624658-22-000001 |
| May 16, 2022 | 10-Q | 0000950170-22-010077 |